Related by context. All words. (Click for frequent words.) 55 REACH Registry 55 Prostate Lung Colorectal 54 Canadian Multicentre Osteoporosis 54 Intervention Trial GAIT 54 cerebral microbleeds 54 Nicotine Addiction 54 Observational studies 53 metaanalysis 53 Pharmacokinetic PK 53 STEP BD 53 Meta analyzes 53 prostate carcinogenesis 53 selenium supplementation 53 Genetic Variation 53 Intervention Effectiveness CATIE 53 Genetic Markers 53 NESARC 53 CATIE 53 WHEL 53 Nord Trøndelag Health 53 Epidemiologic studies 53 phylogenetic analyzes 53 ONTARGET 52 Acute Liver Failure 52 Screening Trial DMIST 52 Secondhand Smoke Exposure 52 Ovarian Cancer Screening 52 Hepatotoxicity 52 Anti Tumor 52 methodological differences 52 Clinical Antipsychotic Trials 52 Insulin Resistance Atherosclerosis 52 BARI 2D 52 CALGB 52 familial aggregation 52 vitamin D inadequacy 52 MERLIN TIMI 52 Stephanie Belloc 52 prospective multicentre 52 Cornea Donor Study 52 SPARCL 52 Preclinical Study 52 INTERHEART study 52 Randomized trials 51 VADT 51 Relieve Depression 51 ACRIN 51 neuropathologic 51 ACCORD Eye 51 Autism Consortium 51 prospective observational studies 51 Cytogenetic 51 GISSI 51 Titus Ernstoff 51 pathogenetic mechanisms 51 Prostate Disease 51 atherothrombotic disease 51 Clinical Trial Data 51 mg BID dose 51 Alpha Tocopherol Beta Carotene 51 dyslipidaemia 51 Molecular Cancer 51 Dr. Pasinetti 51 CCCEH 51 Randomized Controlled Trials 51 Prostate Cancer Prevention 51 Hepatitis C Infection 51 Inflammatory Markers 51 #:#-#,# CrossRef Medline [002] 51 #F FDG PET 51 CARE HF 51 Sociodemographic 51 Predisposition 51 Analytical Method 51 Cholesterol Levels SPARCL 50 retrospective cohort 50 Histopathological 50 Michael Leitzmann 50 Imaging Biomarkers 50 Trandolapril 50 Diabetes Complications 50 subanalysis 50 Emily Oken 50 Ocular Hypertension Treatment 50 Asthma Intervention 50 Singh Manoux 50 HYVET 50 Pharmacologic 50 Diagnostic Criteria 50 immunological responses 50 endophenotypes 50 ConclusionThis 50 genomewide association study 50 etiologic 50 Women Ischemia Syndrome 50 psychodynamic therapy 50 Multivariate analyzes 50 ACCORD Lipid 50 Coronary Artery Calcium 50 Pharmacokinetic 50 meta regression 50 differential gene expression 50 Complications Trial 50 longitudinal studies 50 Cancer Genetic Markers 50 neuroimaging studies 50 Suicidal Behavior 50 clinicopathological 50 Adverse Event 50 Wisconsin Sleep Cohort 50 CAMMS# 50 Chicago Multidisciplinary Symposium 50 subclinical atherosclerosis 50 subgroup analyzes 50 substudy 50 Meta Analysis 50 Clinical Outcome 50 Lancet Oncology journal 50 beta carotene supplementation 50 Therapeutic Effects 50 multiple logistic regression 50 Lipid Lowering Treatment 50 methodological limitations 50 Osteoarthritis Patients 50 Refractory Angina 50 Glucosamine Chondroitin Arthritis 50 ALLHAT 50 Subgroup analysis 50 Neurotoxicity 50 Biological Effects 50 Multiple logistic regression 50 GYTS 50 Atherosclerosis MESA 50 Depressive Symptoms 50 WTCCC 50 Aggressive Reduction 50 Subgroup analyzes 49 PLCO 49 Slone Epidemiology Center 49 Digital Mammographic Imaging 49 Cardiovascular Risk Factors 49 Nonalcoholic fatty liver 49 Redei 49 Framingham Offspring 49 Adverse Childhood 49 Trial PCPT 49 Septic Shock 49 Schoppe Sullivan 49 Sequenced Treatment Alternatives 49 iPrEx study 49 serum folate concentrations 49 Replication NCS R 49 Pluripotent Stem Cells 49 Intervention Trial 49 CARDIA 49 Antipsychotic Drug 49 Outpatient Setting 49 psychiatric morbidity 49 Framingham Offspring Study 49 antioxidant supplementation 49 genetic loci 49 CROI 49 Anti Tumor Activity 49 Carotid Revascularization Endarterectomy vs. 49 Current Author Addresses 49 Cognitive Aging 49 convergent validity 49 familial clustering 49 EORTC 49 ASD prevalence 49 serum leptin 49 Substance Use 49 Neuroepidemiology 49 Regression analysis 49 Multi Ethnic Study 49 Study HERS 49 Longitudinal studies 49 JAK Inhibitor 49 Mien Chie Hung 49 Cancer Prevention ATBC 49 Screening Trial 49 Zevalin consolidation 49 NatCen 49 synthetic lethality 49 Racial Differences 49 HORIZONS AMI 49 Gender Differences 49 Gastric Cancer 49 logistic regressions 49 riociguat 49 chromium supplementation 48 ORAL Solo 48 CURRENT OASIS 7 48 biochemical abnormalities 48 Epidemiological studies 48 chromosome aberrations 48 meta analyzes 48 Intervention Effectiveness 48 Study ADCS 48 Antidepressant Use 48 placebo controlled studies 48 BOLDER II 48 prospective observational cohort 48 fasting serum 48 Univariate analysis 48 Antihypertensive 48 Evaluation WISE 48 PCPT 48 neuropsychiatric symptoms 48 Exelixis XL# 48 NHANES III 48 Systematic Review 48 Electroencephalography 48 Survey MEPS 48 Venous Thromboembolism 48 Risk Behavior 48 Nutrition Examination Surveys NHANES 48 Heritability 48 NLSY 48 follicular adenoma 48 ISPOR 48 Fecal Incontinence 48 ERSPC 48 INTERMAP 48 SABCS 48 periprocedural MI 48 Tumor Response 48 biologic plausibility 48 journal Anticancer 48 Cochrane reviewers 48 Multicenter AIDS 48 unmeasured confounding 48 Dr. Tashkin 48 epidemiological studies 48 Molecular Epidemiology 48 Colorectal Screening 48 National Epidemiologic Survey 48 Cancer Incidence 48 semistructured interviews 48 SWOG 48 genotype phenotype 48 STRIDE PD 48 genetic polymorphisms 48 APOE e4 48 Aggressive Behavior 48 methodologically rigorous 48 surveys Herbenick 48 Rigorous scientific 48 UKPDS 48 chlamydial infection 48 Multivariate logistic regression 48 Dialysis Outcomes 48 NICE SUGAR 48 BCIRG 48 cardioprotective effects 48 Cohort Consortium 48 Cardiac Resynchronization 48 Baltimore Longitudinal Study 48 Weese Mayer 48 CAPRIE 48 Mortality Risk 48 Merikangas 48 ELCAP 48 NATRECOR ® 48 haplotype map 48 multivariable analysis 48 AVADO 48 Nicotine Vaccine 48 chromosomal regions 48 Hertzel Gerstein 48 Nonalcoholic Fatty Liver Disease 48 Heart Failure Therapies 48 KRAS gene mutations 47 Gene Variation 47 KIF6 carriers 47 ExTRACT TIMI 47 journal Hormones 47 BRIM3 47 Breast Tumors 47 serum lipid levels 47 variant rs# 47 Cardiovascular Risk Reduction 47 clinico pathological 47 previously undescribed 47 Michael F. Leitzmann 47 Prostate Cancer Outcomes 47 Genetic Variants 47 Pharmacodynamic 47 ASCO GU 47 Childhood Asthma 47 RE LY trial 47 Prehypertension 47 Levels Linked 47 Cognitive Impairment 47 prenatal exposures 47 pathogenic mechanisms 47 Investigator Initiated 47 eprotirome 47 Postmenopausal Women 47 Borzekowski 47 Yikyung Park 47 Dr. Roehrborn 47 ENDEAVOR clinical 47 univariate 47 epidemiologic studies 47 dysglycemia 47 Hematological Cancers 47 logistic regression models 47 placebo controlled trials 47 Related Conditions NESARC 47 Hematological 47 Prof. Krainer 47 Multicenter Automatic Defibrillator Implantation 47 multicenter placebo controlled 47 Multivariate analysis 47 choline intake 47 NSDUH 47 Kimmie Ng 47 Racial Disparities 47 Study AREDS 47 Phenotypes 47 toxicologic 47 Gene Linked 47 serum selenium 47 prognostic significance 47 EchoCRT 47 NOD mice 47 Criminological 47 IMPROVE HF 47 journal Gynecologic Oncology 47 Skin Lesions 47 prospective longitudinal 47 Trial NLST 47 psychiatric outpatients 47 Amy Abernethy 47 lipid lowering agents 47 prostate cancer CaP 47 SNP rs# [002] 47 meta analysis pooling 47 Stenting Trial CREST 47 retrospective cohort study 47 Histopathologic 47 exploratory endpoints 47 Coronary Revascularization 47 atherogenic dyslipidemia 47 NCCTG N# 47 prenatal phthalate exposure 47 Dr. Kandzari 47 RE LY 47 Vaccine Immunology 47 Meta Analyses 47 multicenter trials 47 AREDS 47 Glucosamine chondroitin Arthritis 47 Stacy Tessler Lindau 47 Epidemiological 47 COMT genotype 47 S. maltophilia 47 p# biomarker 47 Medical Expenditure Panel 47 Melov 47 Behavioral Scientist 47 Psychosomatic Research 47 pharmacogenetic testing 47 Passive Smoking 47 Atorvastatin Evaluation 47 evaluating mipomersen 47 Comorbidity 47 Daryl Bem 47 Epidemiologic 47 MGUS 47 metabolite concentrations 47 thyrotropin levels 47 Inflammatory Bowel Diseases 47 Cancer Stem Cells 47 Chronic Lyme Disease 47 Diabetes ACCORD 47 environmental toxicants 47 Sipuleucel T 47 PLCO trial 47 Communities ARIC study 47 Analytical Tool 47 Insulin Sensitivity 47 Gynecological Cancer 47 schizophrenia schizoaffective disorder 47 Francesca Bravi 47 sociodemographic 47 dietary acrylamide 47 serum vitamin D 47 CTRC AACR San Antonio 47 Acta Scandinavica 47 sociodemographic characteristics 47 DNA methylation markers 47 vitro experiments 47 HMG CoA reductase inhibitors 47 KRAS mutation 47 Mechanistic studies 47 Stress Hormone 47 journal Behavioral Neuroscience 47 Molecular Genetic 47 PON1 activity 47 Serious Adverse Events 46 Radiation Therapy Oncology 46 Demonstrates Efficacy 46 Irva Hertz Picciotto 46 journal Nucleic Acids 46 RE LY ® 46 coronary calcification 46 comorbid disorders 46 Eye Diseases 46 #-# Full Text 46 ARBITER 6 46 multivariate Cox 46 Cognitive Function 46 Genetic Variations 46 conditional logistic regression 46 Lancet Neurology journal 46 PROSTVAC TM 46 Chemotherapeutic Agents 46 Ovarian PLCO Cancer 46 Sherine Gabriel 46 Dr. Yolton 46 Afatinib 46 Lung Cancer Survival 46 Cecilia Ramlau Hansen 46 Ronald DePinho 46 mean ± SEM 46 Logistic regression 46 multivariate analyzes 46 metapopulation 46 Illicit Drug Use 46 CPS ASEC 46 Hakonarson 46 Brain Scans 46 Clinical Orthopaedics 46 Rachel Ballard Barbash 46 Antitumor Activity 46 Paolo Boffetta 46 Comorbidities 46 randomized controlled trials RCTs 46 journal Behavioural Ecology 46 renal cell carcinomas 46 Randomized controlled 46 Abbott Trilipix 46 SNCA 46 Car Naturalistic Driving 46 Endocrine Practice 46 NSABP 46 Neoadjuvant Chemotherapy 46 First Patient Enrolled 46 homocysteine concentrations 46 Hospitalization Rates 46 correlational 46 NO# [002] 46 Contraceptive Use 46 INTERPHONE 46 neurobiological underpinnings 46 Endocrine Society #st 46 Wendie Berg 46 reboxetine 46 iPrEx 46 MAPT 46 #:#-# [035] 46 Deutsches Arzteblatt International 46 AVERROES 46 Lp PLA 2 46 methodologic 46 Research Diagnostic Criteria 46 mechanistic studies 46 Rosuvastatin 46 HCV SPRINT 46 interobserver 46 Rakai Uganda 46 PIB PET 46 HHV 6 46 Brain Wiring 46 Subtypes 46 Gene Variants 46 Prostate AdenoCarcinoma Treatment 46 Calcium Intake 46 polyarticular 46 guideline concordant 46 Cognitive Abilities 46 PREVENT IV 46 CARET 46 Effective Treatments 46 CoQ# supplementation 46 entitled Treatment Algorithms 46 germline mutations 46 perfusion abnormalities 46 nonfasting triglycerides 46 susceptibility loci 46 CATIE AD 46 NHANES #-# 46 Randomized Trials 46 Blood Pressure Drugs 46 Clinical Efficacy 46 Human Mutation 46 folate supplementation 46 confirmatory clinical 46 generalizability 46 randomized controlled clinical trials 46 precaution Wiehle 46 EMPOWER ™ 46 Metabolic Endocrinology 46 epidemiologic 46 Genotypes 46 Gene Mutations 46 Patient Populations 46 Statistical Methods 46 Schizophrenia Treatment 46 Toxicological 46 blinded randomized placebo controlled 46 Jacques Montplaisir 46 CHAMPION PCI 46 clinically evaluable 46 Surgical Outcomes 45 AVOREN 45 multicenter randomized clinical 45 Colorectal Cancers 45 phase IIIb 45 Stop Hypertension diet 45 journal Paediatrics 45 randomized trials 45 NEJM editorial 45 genetic variants associated 45 Krewski 45 observational cohort study 45 journal Psychological Bulletin 45 Echocardiographic 45 Shamay Tsoory 45 STICH trial 45 gallstone disease 45 Platelet Inhibition 45 NABE Outlook 45 Tobias Kurth 45 EUROGIN 45 Markus Heilig 45 Iressa gefitinib 45 Nesiritide 45 mechanistic insights 45 Drug Shows Promise 45 sociodemographic variables 45 Young Adults CARDIA 45 MGd 45 CYP#C# [001] 45 moderately heritable 45 STRATEGY FOR AN OPEN 45 Stent Thrombosis 45 genomewide 45 MADIT CRT 45 carotid IMT 45 Munk Olsen 45 Shows Promise Against 45 ASSERT 45 thoracic aortic disease 45 Nymox NX 45 Oral Anticoagulants 45 Genitourinary Cancers Symposium 45 HIV seropositive 45 postmarketing adverse 45 Laryngeal Cancer 45 journal Transfusion 45 microsatellite markers 45 Coronary artery calcification 45 ACOSOG Z# 45 serum GGT 45 Cervical Dysplasia 45 journal Biomacromolecules 45 Osteoporotic Fractures 45 BERKELEY CA UroToday.com 45 Normative Aging Study 45 T2DM 45 pharmacoeconomic analysis 45 REGARDS 45 HORIZONS AMI trial 45 Repeatable Battery 45 Statin Drugs 45 Dong Chul Seo 45 Bresalier 45 Memory Study WHIMS 45 CLL8 45 ACUITY trial 45 ISEL 45 biologic pathways 45 KRAS variant 45 ASPIRE HIGHER 45 Preclinical Data 45 MEND CABG 45 journal Neuropsychologia 45 EUS FNA 45 Sleep Disturbance 45 Pharmacokinetic parameters 45 longitudinal observational study 45 suicide attempters 45 psychoeducational 45 neurobiological mechanisms 45 underlying pathophysiology 45 National Oncologic PET 45 comorbid depression 45 BMC Musculoskeletal Disorders 45 Beneficial Effects 45 PRESEPT 45 Relieve Depression STAR 45 journal Nicotine 45 Brief Psychiatric 45 International Verapamil SR 45 SEER database 45 Prescription Painkiller 45 Affective Disorders 45 PhG alpha 1 45 Lupus Drug 45 better childproof containers 45 BRCA2 mutation carriers 45 non fasting triglycerides 45 TAXUS IV 45 Ionizing Radiation 45 Burbacher 45 Intimate Partner 45 Celecoxib APC trial 45 Swedish Mammography Cohort 45 MYH9 gene 45 generalisability 45 Amminger 45 vivo assays 45 Logistic regression analysis 45 longitudinal cohort study 45 Edge STudy 45 Healthy Behaviors 45 Alicja Wolk 45 prospective nonrandomized 45 thrombophilia 45 leader Hakon Hakonarson 45 Reduced Risk 45 Lung Injury 45 HF ACTION 45 MADIT CRT trial 45 Antiepileptic Drugs 45 tumor subtypes 45 HRQL 45 bivariate analyzes 45 flurpiridaz F 45 ANCOVA 45 Cancer Incidence Mortality 45 Childhood Vaccinations 45 Lipid Levels 45 tarenflurbil 45 Decety 45 phylogenetically 45 genomewide association studies 45 COPAXONE R 45 depressive symptomatology 45 JoAnn Manson 45 journal Neuropsychology 45 PLOS 45 Vital Statistics System 45 Regression analyzes 45 Statistically Significant 45 bile acid metabolism 45 Cloretazine 45 AIR2 Trial 45 cardiovascular mortality 45 Norman Hollenberg 45 Peter Gotzsche 45 Racial Disparity 45 ICAAC IDSA 45 observational studies 45 journal Molecular Psychiatry 45 Computed Tomographic 45 hyperhomocysteinemia 45 CALGB # [001] 45 Genetic Marker 45 Registry NOPR 45 IL#B 45 AIM HIGH 45 Tor Bjerkedal report 45 DMIST 44 internalizing disorders 44 NCVS 44 testosterone supplementation 44 causal pathways 44 Multicenter Phase 44 Eric Fombonne 44 study1 44 Unequal Treatment 44 Nalini Ranjit 44 Nutrition EPIC 44 Cerebrovascular Diseases 44 Male Infertility 44 C#Y 44 IASLC 44 Geosensing 44 journal Chemosphere 44 AIDS Clinical Trials 44 Combination Treatment 44 Epidemiological Studies 44 Novartis Zometa 44 Multiethnic Cohort Study 44 Antiviral Drugs 44 virginity pledgers 44 J Clin Oncol 44 preclinical efficacy 44 nomograms 44 Radiation Induced 44 & Rheumatism http:/www.interscience.wiley.com/jouTMMWV 44 CDKN2A 44 causal inference 44 CIMZIA ™ 44 genotypic 44 immunohistochemical analysis 44 PROactive study 44 randomizing patients 44 journal Psychosomatic Medicine 44 Acute Coronary Syndromes 44 Philippe Autier 44 recurrent glioblastoma multiforme 44 Multiethnic Study 44 Preterm Birth 44 ChromoCure 44 Enzyme Leach 44 neoadjuvant treatment 44 Phase 2a Trial 44 subscale scores 44 RECORD1 44 Neuroprotective Effects 44 GRAVITAS trial 44 Targeted Molecular Diagnostics 44 PITX2 methylation 44 Kaplan Meier analysis 44 myocardial infarctions MIs 44 Val HeFT 44 univariate analyzes 44 antipsychotic prescribing 44 Oral Fingolimod 44 atherothrombotic 44 HNPCC 44 Breast Cancer Cells 44 florbetaben 44 chromosome #p# [002] 44 Prevalence Worldwide 44 Pooled Analysis 44 neuroanatomical 44 Regulatory Toxicology 44 ABCB1 44 Partnership Attitude Tracking 44 NeuroImage 44 eC SSRS 44 Therapeutic Arthritis 44 Renal Cell Carcinoma RCC 44 neratinib 44 Outcome Measures 44 colorectal adenoma 44 Panksepp 44 NHAMCS 44 meta analysis 44 journal Developmental Psychology 44 histologic findings 44 Paola Sebastiani 44 T1DM 44 HIV AIDS BC CfE 44 sirtuin activators 44 journal Palaios 44 gene polymorphisms 44 Therapeutic Efficacy 44 clinicopathologic 44 postmenopausal hormones 44 CARDIA study 44 SHAPE Task Force 44 Clinical Infectious Disease 44 HPTN 44 NCCAM 44 Cholesterol Levels 44 Prospective Multicenter 44 functional neuroimaging 44 gene rearrangements 44 Randomized Study 44 Stephan Herzig 44 Non Alcoholic Steatohepatitis 44 ongoing Phase IIIb 44 Alcoholism Clinical 44 observational cohort 44 functional gastrointestinal disorders 44 Health Initiative Observational 44 authors hypothesized 44 anthropometric measurements 44 methodological flaws 44 journal Pharmacoepidemiology 44 GPNMB expression 44 Genetic Diversity 44 biomonitoring studies 44 Iron Deficiency 44 pharmacodynamic endpoints 44 detect XMRV 44 CETP inhibition 44 SCD HeFT 44 Health Examination Survey 44 International Neuropsychological Society 44 Breast Tissue 44 pharmacological approaches 44 journal Neuropsychopharmacology 44 & Analgesia retracted 44 bivariate 44 nonrandomized 44 placebo controlled Phase III 44 BioNumerik 44 SIMPADICO 44 placebo controlled clinical 44 Imre Janszky 44 TAXUS VI 44 heterozygous familial 44 residual confounding 44 Crystallographic 44 Makes Recommendations 44 Mayo Clinic oncologist 44 CC genotype 44 Brain Stimulation 44 dietary carotenoids 44 randomized multicenter trial 44 Pregnancy Outcomes 44 Toxicity Testing 44 retrovirus XMRV 44 papillary renal cell carcinoma 44 IKZF1 44 nonpregnant women 44 Ischemic 44 Cochrane Systematic Review 44 PICALM 44 PERISCOPE 44 psychiatric comorbidities 44 Immunomedics Announces 44 Technological Advances 44 Genetic variants 44 journal Molecular Pharmaceutics 44 multicentre prospective 44 Education Next PEPG 44 Clinical Psychology Review 44 Springer journal Naturwissenschaften 44 Hp2 2 44 NHANES 44 Phase Ib Clinical Trial 44 Controlled Trial 44 pharmacological interventions 44 potentially modifiable 44 Interview Survey CHIS 44 Atherosclerosis Risk 44 Mechanistic 44 Coronary CTA 44 phylogenetic analysis 44 chromosome #p#.# 44 ILLUSTRATE 44 Genetics Consortium 44 Findings 44 Whole Genome Sequencing 44 Asthma Treatment 44 Carotid Endarterectomy 44 predictive validity 44 intraobserver 43 prospective observational 43 DAPT Study 43 Reproductive Toxicology 43 KIF6 gene variant 43 PACCE trial 43 Etiology 43 logistic regression model 43 ACS bi weekly 43 serotonin deficiency 43 MADIT II 43 dobutamine stress 43 pathophysiological mechanisms 43 venous thromboembolic disease 43 catechol O methyltransferase COMT 43 #q# [001] 43 Avandia Actos 43 journal Pharmacotherapy 43 Treatment Algorithm 43 Molecular Origins 43 comorbidity 43 Coronary Artery Risk 43 EURIDIS 43 generalized estimating 43 AJPH 43 Vlachopoulos 43 journal Arteriosclerosis Thrombosis 43 Diabetic Medicine 43 journal Behavioral Ecology 43 premorbid 43 KRAS status 43 Long Term Outcomes 43 Clinical Practice Guidelines 43 ABCSG 43 Lung Cancer Screening 43 postmenopausal hormone therapy 43 Preclinical Models 43 Fragile Families 43 ENESTnd 43 TCF#L# 43 Alcohol Dependence 43 RE MODEL 43 Observational Study 43 SWiTCH 43 ICON7 43 Antifungals 43 Analgesia 43 spontaneous preterm delivery 43 Tumor Registry 43 TMC# C# 43 PERSEUS 43 CVD mortality 43 enzastaurin 43 #rd Annual CTRC 43 definite stent thrombosis 43 severe periodontitis 43 FoodNet 43 allele frequencies 43 Lowers Risk 43 FDG PET 43 Nutrition Examination Surveys 43 Cigarette Smoke 43 Shlipak 43 SYNTAX 43 Nature Genetics journal 43 molecular biomarker 43 ADVANCE PD 43 Conclusions 43 pegylated interferon alfa 2b 43 Hypertriglyceridemia 43 Study Shows Significant 43 journal Ophthalmology 43 lipid lowering therapy 43 NEJM 43 OBJECTIVES 43 journal Resuscitation 43 virological response 43 Phylogenetic analyzes 43 Rheumatoid Arthritis Patients 43 nondemented 43 NSABP B 43 MERIT ES 43 ASCEND HF 43 Bjelakovic 43 noscapine 43 Multicenter 43 Schiavo Autopsy 43 Long Term Efficacy 43 Ischemic Heart Disease 43 Bioassays 43 BMC Neuroscience 43 cardiac computed tomography 43 Ajit Varki 43 Risk Longitudinal 43 SF #v# 43 Associated Press Ipos poll 43 REALITY Trial 43 Long Term Survival 43 #p# [003] 43 NATRECOR R 43 Neurocognitive 43 Bruce Psaty 43 Employee Motivation 43 prognostic variables 43 Survival Rates 43 RIO Lipids 43 facial clefts 43 Patient Registry 43 XMRV virus 43 Demonstrates Sustained 43 CaPSURE 43 Test Detects 43 PrEP trials 43 empirically validated 43 Differential Diagnosis 43 Children Brain Tumour 43 Epilepsy Drug 43 #th Interscience Conference 43 pharmacokinetic pharmacodynamic 43 Clinical Cardiology 43 coinvestigators 43 NCCTG 43 EMBO Molecular Medicine 43 racemic baclofen 43 EGIR 43 clinical pharmacology studies 43 Gisselquist 43 journal CyberPsychology 43 Posttraumatic stress disorder 43 WHIMS 43 ENGAGE AF TIMI 43 journal Evolutionary Psychology 43 Endocrine Disruptors 43 Neoplasia 43 Unmet Medical 43 dietary questionnaires 43 HbA 1c 43 Survival Benefit 43 Survivor Study CCSS 43 nanowire sensors 43 Proves Effective 43 lignan intake 43 HIV seronegative